These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 22915313)
1. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria. Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria. Lu J; Yoshida O; Hayashi S; Arimoto H Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629 [TBL] [Abstract][Full Text] [Related]
3. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. Griffin JH; Linsell MS; Nodwell MB; Chen Q; Pace JL; Quast KL; Krause KM; Farrington L; Wu TX; Higgins DL; Jenkins TE; Christensen BG; Judice JK J Am Chem Soc; 2003 May; 125(21):6517-31. PubMed ID: 12785792 [TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria. Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534 [TBL] [Abstract][Full Text] [Related]
5. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives. Yao NH; Liu G; He WY; Niu C; Carlson JR; Lam KS Bioorg Med Chem Lett; 2005 May; 15(9):2325-9. PubMed ID: 15837318 [TBL] [Abstract][Full Text] [Related]
6. [Recent advances in the study of synthesis and activity of vancomycin derivatives]. Chen YY; Liu G Yao Xue Xue Bao; 2007 May; 42(5):463-9. PubMed ID: 17703765 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel protein synthesis inhibitor active against gram-positive bacteria. Eibergen NR; Im I; Patel NY; Hergenrother PJ Chembiochem; 2012 Mar; 13(4):574-83, 490. PubMed ID: 22362659 [TBL] [Abstract][Full Text] [Related]
8. Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B. Yoshida O; Yasukata T; Sumino Y; Munekage T; Narukawa Y; Nishitani Y Bioorg Med Chem Lett; 2002 Nov; 12(21):3027-31. PubMed ID: 12372494 [TBL] [Abstract][Full Text] [Related]
15. Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]-Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE. Silverman SM; Moses JE; Sharpless KB Chemistry; 2017 Jan; 23(1):79-83. PubMed ID: 27747932 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives. Zhang SJ; Yang Q; Xu L; Chang J; Sun X Bioorg Med Chem Lett; 2012 Aug; 22(15):4942-5. PubMed ID: 22765891 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial evaluation of novel 8-fluoro Norfloxacin derivatives as potential probes for methicillin and vancomycin-resistant Staphylococcus aureus. Sunduru N; Gupta L; Chauhan K; Mishra NN; Shukla PK; Chauhan PM Eur J Med Chem; 2011 Apr; 46(4):1232-44. PubMed ID: 21345548 [TBL] [Abstract][Full Text] [Related]
18. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1. Bremner JB; Keller PA; Pyne SG; Boyle TP; Brkic Z; David DM; Robertson M; Somphol K; Baylis D; Coates JA; Deadman J; Jeevarajah D; Rhodes DI Bioorg Med Chem; 2010 Apr; 18(7):2611-20. PubMed ID: 20236828 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of bis, tris and tetra(dihydrocaffeoyl)polyamine conjugates as antibacterial agents against VRSA. Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A Arch Pharm Res; 2008 Jun; 31(6):698-704. PubMed ID: 18563350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]